Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Sees Unusually-High Trading Volume – What’s Next?

Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) saw unusually-high trading volume on Friday . Approximately 36,265 shares traded hands during mid-day trading, an increase of 37% from the previous session’s volume of 26,468 shares.The stock last traded at $14.30 and had previously closed at $16.15.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on the company. William Blair reissued an “outperform” rating on shares of Telix Pharmaceuticals Limited American Depositary Shares in a report on Wednesday, March 12th. UBS Group lifted their target price on Telix Pharmaceuticals Limited American Depositary Shares from $21.00 to $22.00 and gave the company a “buy” rating in a research note on Monday, January 27th.

Telix Pharmaceuticals Limited American Depositary Shares Trading Down 15.7 %

The stock’s 50 day simple moving average is $17.79.

About Telix Pharmaceuticals Limited American Depositary Shares

Telix Pharmaceuticals Ltd. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals.